(Q35467498)

8 August 2017

1 reference

title

NEUROLOGICAL SYMPTOMS IN PHARMACOTHERAPY OF PSYCHOSES (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14217630

2 February 2024

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14217630

2 February 2024

Tranquilizing agents

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14217630

2 February 2024

extrapyramidal tract

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14217630

2 February 2024

author name string

FAURBYE A

1

1 reference

8 August 2017

RASCH PJ

2

1 reference

8 August 2017

PETERSEN PB

3

1 reference

8 August 2017

BRANDBORG G

4

1 reference

8 August 2017

PAKKENBERG H

5

1 reference

8 August 2017

A. Faurbye

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14217630

2 February 2024

P. J. Rasch

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14217630

2 February 2024

P. B. Petersen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14217630

2 February 2024

G. Brandborg

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14217630

2 February 2024

H. Pakkenberg

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14217630

2 February 2024

language of work or name

English

0 references

publication date

1 January 1964

1 reference

full work available at URL

8 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1600-0447.1964.tb05731.x

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1964.TB05731.X

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1600-0447.1964.tb05731.x

2 February 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1964.TB05731.X

Acta Psychiatrica Scandinavica

2 February 2024

published in

1 reference

8 August 2017

volume

40

1 reference

8 August 2017

page(s)

10-27

1 reference

Excretion of dopamine in diseases of basal ganglia.

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1964.TB05731.X

3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1964.TB05731.X

Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1964.TB05731.X

Drug-induced extrapyramidal reactions. Treatment with diphenhydramine hydrochloride and dihydroxyphenylalanine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1964.TB05731.X

An Effect of Chlorpromazine on Rat Mitochondrial Membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1964.TB05731.X

A survey of drug-induced extrapyramidal reactions

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1964.TB05731.X

Interactions between reserpine, chlorpromazine, and imipramine

2 February 2024

11

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1964.TB05731.X

Further studies on the metabolic background of tranquilizing drug action

2 February 2024

12

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1964.TB05731.X

Therapeutic value of thioproperazine and the importance of the associated neurological disturbances

2 February 2024

13

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1964.TB05731.X

Chronic involuntary movements induced by phenothiazines

2 February 2024

16

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1964.TB05731.X

Persistent muscular restlessness after phenothiazine treatment: report of 3 cases

2 February 2024

28

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1964.TB05731.X

Mental function and cerebral oxygen consumption in organic dementia.

2 February 2024

30

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1964.TB05731.X

[Thiaxanthene derivatives and similar substances. Chemistry and pharmacology of the substances]

2 February 2024

36

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1964.TB05731.X

The accumulation of S35-chlorpromazine in brain.

2 February 2024

39

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1964.TB05731.X

2 February 2024

Identifiers

1 reference

8 August 2017

1 reference